business
Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)
Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)
Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop